Hemophilia Clinical Trials

A listing of Hemophilia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 101 clinical trials
A Study to Evaluate the Pharmacokinetics Safety and Tolerability of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection

patients with severe hemophilia A. The secondary objectives are to monitor anti-durg antibodies and anti-PEG antibodies levels in patients with severe hemophilia A

  • 2 views
  • 26 Jul, 2021
  • 4 locations
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Phase IV multi-center, US-centric, open-label, safety study enrolling participants with Hemophilia A or B with inhibitors aged 12 to 65 years, inclusive, who are either on long term prophylactic

  • 0 views
  • 18 Dec, 2021
  • 13 locations
A Research Study of How a New Medicine NNC0365-3769 (Mim8) Works in the Body of Healthy People

NN0365-3769 (Mim8) is a study medicine with the potential to prevent and reduce bleeding in people with haemophilia A (an inherited disorder in which blood does not coagulate properly).

Accepts healthy volunteers
  • 0 views
  • 02 Jan, 2022
  • 2 locations
Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV With Hemophilia.

To evaluate the safety and tolerability of OP-724 in liver cirrhosis patients caused by HIV/HCV co-infection with hemophilia.

hypertension
fibroscan
  • 0 views
  • 10 Oct, 2021
  • 1 location
Phase 1/2 Dose Confirmation Study of FLT180a in Hemophilia B

Study of FLT180a gene therapy in adults with Hemophilia B. Up to 9 patients will be enrolled to receive a single dose of FLT180a and be followed for 52 weeks. Results will confirm the dose for a

  • 0 views
  • 16 Jan, 2022
  • 1 location
Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B

Long-term safety and efficacy follow-up for participants with Hemophilia B who were previously treated in the C0371005 (formerly SPK-9001-101) study, and a dose-escalation sub-study evaluating

hemophilia
  • 145 views
  • 02 Sep, 2021
  • 17 locations
EffectsOfTranscranialPulseStimulationOnDepression-PilotRCT

disorder or schizophrenia); 2) Alcohol or substance dependence; 3) Concomitant unstable major medical conditions or major neurological conditions such as brain tumour, brain aneurysm; 4) Haemophilia or

  • 0 views
  • 22 Aug, 2021
  • 1 location
Glycemic Outcomes and Safety With Minimed 780G System in Children With Type 1 Diabetes Aged 2-6 Years

daily dose) 8 units, 2) HbA1c < 10%, 3) capability to use pump and the CGM, and 4) time from diabetes diagnosis more than 6 months. The exclusion criteria are hemophilia or any other bleeding

hemoglobin a1c
diabetes
diabetic ketoacidosis
insulin
  • 0 views
  • 02 Sep, 2021
  • 1 location
Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected Patients

with chronic hepatic disease, hemophilia, liver transplantation, occupational exposure, MSM, persons who use injection or noninjection illicit drugs, or persons traveling to or working in countries

  • 0 views
  • 25 Mar, 2021
  • 1 location
Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

The aim of this therapeutic education program is to reduce the apparition of immune-related Adverse Event with patients treated with ICI

kidney cancer
carcinoma
cancer
  • 0 views
  • 23 May, 2021
  • 11 locations